Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics

Autor: Burcu Arslan, Halis Şimşek, Salih Tokmak, Ali Demir, Abdulalh Sonsuz, Hikmet Akkiz, Tuncer Temel, Gökhan Karakülah, Engin Altintaş, Ahmet Bektaş, Brian I. Carr, Figen Doran, Sezai Yilmaz, Tolga Akcam, Oğuz Üsküdar, Y. Tokat, Aslı Suner, Mehmet Demir, Tuğsan Ballı, Necati Örmeci, Mehmet Yücesoy, Ahmet Uygun, Sedef Kuran, Anıl Delik, Murat Kilic, Abdulalh Ülkü, Halil İbrahim Bahçeci, Nazım Ekinci, Ayşegül Özakyol, Kamil Yalçın Polat, Kendal Yalcin

Publikováno v: Journal of translational science

Introduction Several markers of systemic inflammation, including blood C-reactive protein, platelet lymphocyte ratio (PLR) and neutrophil lymphocyte ratio (NLR) have been identified as independent prognosticators for hepatocellular carcinoma (HCC). M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcf092ff7a3eb32cd376d336771eae0
https://pubmed.ncbi.nlm.nih.gov/30662766

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The patient burden of opioidinduced bowel dysfunction

Autor: Anıl Delik, Halil İbrahim Bahçeci, Kamil Yalçın Polat, Tuğsan Ballı, Murat Kilic, Brian I. Carr, Oğuz Üsküdar, Ümit Karaoğullarından, Halis Şimşek, Mehmet Yücesoy, Sedef Kuran, Hikmet Akkiz, Necati Örmeci, Kendal Yalcin, Mehmet Demir, Sezai Yilmaz, Nazım Ekinci, Ayşegül Özakyol, Guerra, Ahmet Uygun, Figen Doran, Y. Tokat, Ali Demir, Salih Tokmak, Altntaş E, Tolga Akcam, Burcu Arslan, Abdulalh Ülkü, Abdulalh Sonsuz

Publikováno v: Hyldahl, S, Grønlund, D, Drewes, A & Brock, C 2018, ' The patient burden of opioidinduced bowel dysfunction ', Clinical Practice (Therapy), vol. 15, no. 4, pp. 775-784 . https://doi.org/10.4172/clinical-practice.1000409

C-reactive protein (CRP) is a blood marker for inflammation and is an independent prognostic factor for many human cancers. Combined with albumin levels, it forms the basis of the Glasgow Index for cancer prognosis. We reviewed the literature on CRP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8cac12c7b672d65eea2f70e98b6fab
https://vbn.aau.dk/da/publications/f16124b3-98d1-41ca-a9dd-3645c025a754